Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy

Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy

Administration of autologous mesenchymal stem cells (MSCs) has been shown to improve renal function and histological findings in acute kidney injury (AKI) models. However, its effects in chronic kidney disease (CKD) are unclear, particularly in the clinical setting. Here, we report our experience wi...

Full description

Bibliographic Details
Main Authors: Jun-Seop Kim, Jong-Hak Lee, Owen Kwon, Jang-Hee Cho, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Yong-Jin Kim, Yong-Lim Kim
Format: Article
Language:English
Published: The Korean Society of Nephrology 2017-06-01
Series:Kidney Research and Clinical Practice
Subjects:
Autologous transplantation
Chronic kidney disease
Mesenchymal stem cells
Online Access:https://doi.org/10.23876/j.krcp.2017.36.2.200

Similar Items

Similar Items